Prevalence of Rectal Carcinoid Tumors among Outpatient Colonoscopy Patients and the Utility of Immunohistochemistry for Definitive Diagnosis

Rectal carcinoid tumors are rare (0.05% in the general population, SEER data) and are usually discovered incidentally in routine colonoscopy biopsies. Although immunohistochemistry with neuroendocrine markers synaptophysin and/or chromogranin is often used to confirm the diagnosis, its utility is not well established. The aims of this study were to (1) determine the prevalence of rectal carcinoid tumors in a large cohort of US outpatient colonoscopy patients and (2) evaluate whether the routine use of immunohistochemical stains is necessary for a definitive diagnosis.

To read the rest of this article, please contact Miraca Life Sciences

Choose Miraca for Your Patients

Learn more about Miraca's Anatomic Pathology services

Learn More »
TRADESHOWS >> FIND posters and presentations from past shows, and see where Miraca Life Sciences will be next.

And if you’re using EMA, you sure should be using Miraca. I can’t express enough how helpful Miraca has been to us.
— Rihanna Flanagan, PA-C,
Associates South Shore Dermatology, Quincy, Mass.

Learn about Miraca's unmatched quality. We provide our clients with access to the highest quality AP services.
Get news from Miraca. Join our email list.